Triolyte Trademark Details

Triolyte was registered on Tuesday, July 29, 1986 and is currently owned by Bristol-Myers Company under the registration number 1402808 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 31 years ago on Monday, February 1, 1993, according to the United State Patent & Trademark Office
Word Mark Triolyte
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Bristol-Myers Company of New York, NY

View all trademarks for Bristol-Myers Company
Other Trademarks for Bristol-Myers Company
Serial Number 73566166
Registration Number 1402808
Status Date Monday, February 1, 1993
Filing Date Monday, February 1, 1993
Registration Date Tuesday, July 29, 1986
Attorney Marcella A. Stapor

Correspondent

MARCELLA A. STAPOR
BRISTOL-MYERS COMPANY
345 PARK AVENUE
NEW YORK, NEW YORK 10154

Case File Statements

Goods & Services Combination of Benzocaine and Ephedrine Sulphate Used as an Ingredient of Ointment and Suppositories
Pseudo Mark Trio Lite Trio Light Triolite Triolight

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Monday, February 1, 1993
First Use Anywhere Tuesday, November 1, 1955
First Use In Commerce Tuesday, November 1, 1955
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.